SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Renovo Plc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (29)6/20/2007 3:29:56 PM
From: nigel bates   of 40
 
I've made worse...

..and plenty of them.

Dunno about the choice of partner, though.

Product focus ?

shire.com
Shire, a global specialty pharmaceutical company, has a strategic R&D focus on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI), renal diseases and human genetic therapies...

Nah.

R&D and/or manufacturing expertise ?

...Sales and marketing is a core Shire competence, where effective targeting of prescribers allows maximisation of sales by a relatively small but high quality sales force.
Shire combines investment in product development with careful attention to risk management. Shire avoids involvement in the highest risk area of discovery research for small molecules or research into genomics. Shire’s research and development focus is on late stage, lower risk projects in areas where the company has commercial presence....


Probably not.

Have to say that I like their eye for the main chance, though.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext